[18] reported that PRMT5 activated lipid metabolic reprogramming through MYC, contributing to the growth and survival of mantle cell lymphoma, while the exact regulation mechanism between PRMT5 and MYC is less addressed. This evidence concerns the gene MYC and mantle cell lymphoma.